Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
07/31/2009
Trade Name:
Xerese
Generic or Proper Name (*):
acyclovir/ hydrocortisone
Indications Studied:
Recurrent herpes labialis (cold sores) in 12 years of age and older
Therapeutic Category:
Antiviral, topical
Ages Studied:
12 years and older
Study #:
1
Study Type:
Safety
Study Design:
Open Label
No Patients:
254
No Centers:
26
No Countries:
2
BPCA(B), PREA(P):
P
-
-